Drug Topics

JUNE 16, 2025

[link] Recent Videos Related Content Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.

Specialty Pharmacies

European Pharmaceutical Review

OCTOBER 10, 2022

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline Biologicals’ Boostrix vaccine for use in pregnant woman in their third trimester, to prevent against whooping cough (pertussis) in infants up to two months of age. Since 2012, the CDC has recommended the vaccine series during the third trimester of each pregnancy.

Vaccines

Pharmaceutical Technology

OCTOBER 10, 2022

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed [Tdap]) for pregnant women during their third trimester to prevent pertussis (whooping cough) in newborn infants.

Vaccines

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines

The Checkup by Singlecare

SEPTEMBER 5, 2023

When you or your child get a vaccine, it’s natural to wonder about possible side effects. The meningitis vaccine is recommended for pre-teens , teens, and specific high-risk individuals with certain health conditions. As with most vaccines, mild side effects are common after the meningitis vaccine.

Vaccines

pharmaphorum

JULY 6, 2021

The new figures – from the BioIndustry Association and Clarivate – were dominated by more than £1 billion in venture capital funding for UK biotech and life sciences companies, headlined by DNA sequencing company Oxford Nanopore’s £195 million raise in May that was just shy of the £205 million record set by Immunocore in 2005.

Documentation

STAT

DECEMBER 13, 2024

Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2 billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022.

Pharmaceutical Companies

pharmaphorum

JANUARY 27, 2023

The recent reversal of China’s “zero Covid” policy, at a time when the country still lacks optimal vaccine coverage, has also created another unknown, in terms of global supply and demand forecasting. He previously held regional leadership roles at Sandoz between 2005 and 2010.

Packaging

pharmaphorum

SEPTEMBER 18, 2020

Between 2001 and 2005, Nexium netted AstraZeneca approximately $14.4 AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company, for £120 million in 2005. In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2

Pharmaceutical Companies

pharmaphorum

NOVEMBER 23, 2021

Entrepreneur brothers Thomas and Andreas Struengmann – who hold a stake in COVID-19 vaccine developer BioNTech – have history in the generics sector, having sold drugmaker Hexal to Sandoz in 2005, said Reuters. It also said other private equity groups have taken an interest in Sandoz.

Vaccines

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Just as mRNA and COVID-19 showed the world that it’s possible to develop vaccines much faster, Del Bourgo explains, AI can help us develop new genomic medicines in a more efficient way.

Immunization

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.

Pharmaceutical Companies

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

FDA

pharmaphorum

MARCH 14, 2022

Janssen’s Roz Bekker, VP Commercial Strategy for Infectious Diseases & Vaccines at Janssen EMEA, looks at how COVID-19 has reinforced the value of connecting with people, and how healthcare systems need ongoing reform to deliver more holistic, human-centric care. The connecting effect of COVID-19.

Vaccines

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines

PharmaShots

APRIL 13, 2023

The company also granted exclusive marketing rights to Meda for Cibacen and Cibadrex in major EU markets for $0.13B In the year 2005, Bayer’s sales depicted an increase of 18%, attributable mainly due to its consumer health business acquired from Roche Abbott achieved a total revenue of $1.4B compared to 2015. to the total revenue.

Vaccines

Pharmaceutical Technology

OCTOBER 28, 2022

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. For example, the Covid-19 pandemic brought messenger ribonucleic acid (mRNA) vaccines into international prominence. Because mRNA is highly unstable, these vaccines have had to be stored and/or transported at -80°C to avoid degradation.

Vaccines

ISPE

AUGUST 30, 2022

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. Published November 2005. Case Studies.

Documentation

PharmaShots

MARCH 9, 2023

Designation: Executive Chairperson Award & Nominations: Kiran has been honored with two of India’s prestigious civilian awards: Padma Shri (1989) and Padma Bhushan (2005). Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. Birthplace: Romana was born and brought up in Toronto.

Pharmaceutical Companies

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization

PharmaShots

JANUARY 31, 2023

Funding Value: $7M Founded Year: 2005 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. The company bagged its $6.3M

Vaccines

ISPE

SEPTEMBER 11, 2023

Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” www.fiercepharma.com/manufacturing/sanofi-pumps-554m-into-new-vaccine-manufacturing-facility-eastern-france 41 Boccard. New Project: Evolutive Vaccines Facility for Sanofi.” www.boccard.com/evolutive-vaccines-facility-for-sanofi/ 42 Amgen.

Health and Personal Care Stores

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022.

Vaccines

The Checkup by Singlecare

JANUARY 12, 2023

Archives of General Psychiatry , 2005 ). Archives of General Psychiatry , 2005 ). Harvard National Comorbidity Survey , 2005). A fear of needles ( trypanophobia) causes up to 16% of adults to avoid getting vaccines. The least reported phobia was agoraphobia without panic in the 2005 Harvard National Comorbidity Survey.

Vaccines

ISPE

MARCH 8, 2023

Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S. In the Moderna COVID-19 vaccine contamination case, three lots of the five lots affected, totaling 1.63 1–2 (2005): 20–29. link] 12 MacDonald, M.

Compounding

European Pharmaceutical Review

AUGUST 10, 2022

countries with manufacturing capacity for diagnostics, vaccines and therapeutics. Monkeypox is a disease caused by a zoonotic orthopoxvirus (the monkeypox virus) with similar but less severe symptoms to smallpox – a related disease eradicated through vaccination campaigns by May 1980 – including a rash and fever. But what is monkeypox?

Vaccines

European Pharmaceutical Review

OCTOBER 2, 2023

The Nobel Assembly has awarded Hungarian biochemist Katalin Karikó and US immunologist Drew Weissman the Nobel Prize in Physiology or Medicine 2023 for their breakthrough findings in RNA vaccine development. The discovery was critical for developing effective mRNA vaccines during the COVID-19 pandemic.

Vaccines

European Pharmaceutical Review

OCTOBER 30, 2023

Vaccitech’s Chief Business Officer, Graham Griffiths, discusses key learnings in drug and vaccine development , the challenges of preparing for the unknown, and how strategic collaboration is imperative to achieve faster and more equitable outcomes – if and when another pandemic strikes.

Vaccines

The Checkup by Singlecare

AUGUST 3, 2023

decrease in the rate of lung cancer mortality between 2005 and 2016. ( Between 2013 and 2019, prostate cancer had a 5-year survival rate of 97.1%. ( NCI , 2023) It’s estimated that 288,300 American men will be diagnosed with prostate cancer in 2023. ( 2023 ( NCI , 2023) In 2020, more than 3 million men had prostate cancer in the U.S.(

Chemotherapy

European Pharmaceutical Review

AUGUST 29, 2024

5 Preventing spread of the mpox virus To help prevent more cases of the virus, the CDC recommended that individuals who have had exposure to the virus and those at risk of infection are given two doses of biotech Bavarian Nordic’s vaccine JYNNEOS ® (MVA-BN).

Vaccines

pharmaphorum

JANUARY 21, 2021

Woodcock has most recently been working with the Operation Warp Speed coronavirus vaccine and drug project started by the Trump administration. She held several other roles at CBER before being named as director of the FDA’s Center for Drug Evaluation and Research in 1994 and staying in that role until 2005.

FDA